Symmetrical Drug-Related Intertriginous and Flexural Exanthema-Like Eruption Associated with COVID-19 Vaccination

    Puo Nen Lim, Grant Wylie
    New to Prednisolone? There is a guide in the encyclopedia. Read the guide →
    Studysummary This case report describes a drug-related skin eruption following AstraZeneca-Oxford vaccination, which resolved after treatment with oral prednisolone.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This document described a case of a symmetrical drug-related intertriginous and flexural exanthema-like eruption that occurred after receiving the ChAdOx1 nCoV-19 (AstraZeneca-Oxford) COVID-19 vaccine. Investigations, including repeated skin swabs, ruled out an infectious cause for the skin eruption. The patient was treated with oral prednisolone, which successfully resolved the symptoms.
    Discuss this study in the Community →